Matches in Nanopublications for { ?s ?p "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP806275.RAbjl8Gfp4Vqi-FX4PAWTCMzKMYOpryAnhsc3nPJOMwR4130_assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806275.RAbjl8Gfp4Vqi-FX4PAWTCMzKMYOpryAnhsc3nPJOMwR4130_provenance.
- NP433781.RAKmaTczSlBWtpv_XPdd84WkC-qIPqpO7UZNrSmi07YcM130_assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433781.RAKmaTczSlBWtpv_XPdd84WkC-qIPqpO7UZNrSmi07YcM130_provenance.
- assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP619246.RAfp-ZpO8tUqJCeE_s1BBYLpghmhYBPuiIXBe5Cj7psPM130_assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619246.RAfp-ZpO8tUqJCeE_s1BBYLpghmhYBPuiIXBe5Cj7psPM130_provenance.
- NP619248.RAVWcIaYe4XTSr080c3ZYz5vjYWkm2bfjVIYZDjWbT6oA130_assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619248.RAVWcIaYe4XTSr080c3ZYz5vjYWkm2bfjVIYZDjWbT6oA130_provenance.
- assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP927497.RAvwgwPgsvVsWYtPVyxgm3gM_TRjZsPQCUFt2U0wG6R34130_assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927497.RAvwgwPgsvVsWYtPVyxgm3gM_TRjZsPQCUFt2U0wG6R34130_provenance.
- NP434641.RAnYIGoXTYjKDok3hR1hY4jW9SZ2_u-jj_d3zZ8sy6oPI130_assertion description "[NMDA receptor Type 2B (NMDAR2B) is a candidate TSG first identified in esophageal squamous cell carcinoma (ESCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434641.RAnYIGoXTYjKDok3hR1hY4jW9SZ2_u-jj_d3zZ8sy6oPI130_provenance.